Related Experiment Video
Updated: May 17, 2026

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
Published on: July 19, 2019
Low degree of cortical pathology is associated with benign course of multiple sclerosis
Massimiliano Calabrese1, Alice Favaretto, Valentina Poretto
1The Multiple Sclerosis Centre of the Veneto Region, First Neurology Clinic, Department of Neurosciences, University Hospital of Padova, Italy. calabresem@hotmail.it
Background:
Although a more favorable course of multiple sclerosis is associated with a low degree of cortical pathology, only longitudinal studies could definitely confirm this association.
Materials And Methods:
We followed 95 early relapsing-remitting MS (RRMS; median Expanded Disability Status Scale (EDSS) = 1.5, mean disease duration = 3.1 ± 1.3 years) and 45 benign MS patients (EDSS ≤ 3.0, disease duration ≥ 15 years, normal cognition) for 6 years, with EDSS evaluations every 6 months and brain magnetic resonance imaging (MRI) at baseline and then yearly.
Results:
At baseline, we detected 406 cortical lesions (CLs) in 67/95 (70.5%) early RRMS and in 24/45 (53.3%) benign MS patients (p = 0.046). After 6 years, the appearance of new CLs was observed in 80/95 (84.2%; 518 CLs) of our early RRMS and in 25/45 (55.5%; 63 CLs; p < 0.001) benign MS patients. At baseline, after corrections for age and disease duration, we observed a cortical thinning of several frontal and temporal regions in our RRMS study patients, compared to the benign MS patients (p ranging between 0.001-0.05). After 6 years, the cortical thinning had increased significantly in several cortices of RRMS patients, but only in the occipital-temporal (p = 0.036) and superior parietal gyrus (p = 0.035) of those with benign MS. Stepwise regression analysis revealed the CL volume (p = 0.006) and the cortical thickness of the temporal middle (p < 0.001), insular long (p < 0.001), superior frontal (p < 0.001) and middle frontal gyri (p < 0.001) as the most sensitive independent predictors of a favorable disease course.
Conclusions:
Our data confirmed that a significantly milder cortical pathology characterizes the most favorable clinical course of MS. Measures of focal and diffuse grey matter should be combined to increase the accuracy in the identification of a benign MS course.
Insights
A milder cortical pathology is linked to a more favorable multiple sclerosis (MS) course. Longitudinal study confirms reduced cortical lesions and thinning predict a benign MS progression, aiding in early identification.
Area of Science:
- Neuroscience
- Immunology
- Radiology
Background:
- Multiple sclerosis (MS) is a chronic neurological disease characterized by demyelination and neurodegeneration.
- Cortical pathology, including lesions and thinning, is increasingly recognized as a significant contributor to MS progression.
- Longitudinal studies are crucial to confirm the association between cortical pathology and disease course.
Purpose of the Study:
- To longitudinally assess the relationship between cortical pathology and clinical disease course in early relapsing-remitting MS (RRMS) versus benign MS.
- To identify predictors of a favorable MS disease course based on cortical lesion load and grey matter atrophy.
Main Methods:
- A 6-year longitudinal study followed 95 early RRMS patients and 45 benign MS patients.
- Expanded Disability Status Scale (EDSS) and brain MRI (including cortical lesion counts and thickness) were assessed regularly.
- Statistical analyses, including stepwise regression, were used to determine the association between imaging findings and disease course.
Main Results:
- At baseline, RRMS patients had more cortical lesions (CLs) and greater cortical thinning in several regions compared to benign MS patients.
- Over 6 years, new CLs and increased cortical thinning were significantly more prevalent in RRMS patients.
- Cortical lesion volume and thickness in specific frontal and temporal regions were identified as sensitive predictors of a favorable MS course.
Conclusions:
- Milder cortical pathology is a key characteristic of a more favorable multiple sclerosis clinical course.
- Combining measures of focal and diffuse grey matter pathology improves the accuracy of identifying benign MS.
- These findings underscore the importance of monitoring cortical changes in MS management.
More Related Videos
09:46Rat Model of Widespread Cerebral Cortical Demyelination Induced by an Intracerebral Injection of Pro-Inflammatory Cytokines
Published on: September 21, 2021
12:23Dynamic Visual Tests to Identify and Quantify Visual Damage and Repair Following Demyelination in Optic Neuritis Patients
Published on: April 14, 2014
Related Concept Videos
Multiple Sclerosis l: Introduction
Alzheimer Disease ll: Pathophysiology
Secondary Spinal Cord Injury llI: Pathophysiology
Encephalitis ll: Pathophysiology
Neural Regulation
Parkinson Disease ll: Pathophysiology